Triple-Negative Breast Cancer (TNBC) Terminated Phase 2 Trials for Veliparib (DB07232)

Also known as: Triple-negative Breast Cancer

IndicationStatusPhase
DBCOND0067309 (Triple-Negative Breast Cancer (TNBC))Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01306032Phase II ABT-888 With CyclophosphamideTreatment